The Kraft Group — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Scholar Rockscholarrock.com in 𝕏NASDAQ: SRRKSep 2014

Scholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases.

BiotechCambridge, US

Nagesh Mahanthappa(Executive Officer, Director)inTimothy Springer(Director)David Hallal(Chief Executive Officer, Chairman and Director)inAkshay Vaishnaw(President of Research & Development and Director)inR. Keith Woods(Chief Operating Officer)inVikas Sinha(Chief Financial Officer)in

Co-investorsAisling Capital ARCH Venture Partners EcoR1 Capital Polaris Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.